Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2010
12/23/2010WO2010147094A1 Compound having spiro-bonded cyclic group and use thereof
12/23/2010WO2010146236A1 Urea substituted sulphonamide derivatives
12/23/2010WO2010146177A1 Bone marrow extracellular matrix extract and therapeutic use thereof
12/23/2010WO2010146155A1 Gelled iron veterinary suspension
12/23/2010US20100324107 USE OF PHTHALIMIDE AND/OR SULPHONAMIDE DERIVATIVES IN THE TREATMENT OF DISEASES WHICH REQUIRE REDUCING THE TNF-alpha LEVELS AND AN EXOGENOUS SOURCE OF NITRIC OXIDE, PHTHALIMIDE DERIVATIVES, SULPHONAMIDE DERIVATIVES, AND A METHOD FOR OBTAINING A SULPHONAMIDE DERIVATIVE
12/23/2010US20100324091 Pyrazolone Derivative
12/23/2010US20100324063 Jak2 tyrosine kinase inhibition
12/23/2010US20100324058 thrombin function compounds and pharmaceutical compositions based on them
12/23/2010US20100324005 Method for treatment of diseases
12/23/2010US20100323999 Therapeutic Molecules and Methods-1
12/23/2010US20100323991 Methods and products for treatment of diseases
12/23/2010US20100323986 Compositions and methods for modulation of vascular structure and/or function
12/23/2010US20100323969 Compounds Binding to P-Selectin
12/23/2010US20100323966 FVIII Peptides and Their Use in Tolerising Haemophiliacs
12/23/2010US20100323965 Thrombopoietin Mimetics
12/23/2010US20100323961 Surface eroding sutures
12/23/2010US20100323029 Five-coordinate neuroglobin and use thereof as a blood substitute
12/23/2010US20100323020 Stable nanoparticulate drug suspension
12/23/2010US20100322998 Skin ulcer preventive curative agent containing human recombinant hgf
12/23/2010US20100322978 Medical composition
12/23/2010US20100322948 Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same
12/23/2010US20100322921 METHOD OF INHIBITING COAGULATION ACTIVATION WITH HUMAN ANTI-FACTOR Va ANTIBODIES AND USE THEREOF
12/23/2010US20100322907 Expansion of Hematopoietic Stem Cells
12/23/2010US20100322870 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
12/23/2010US20100322869 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
12/23/2010CA2765847A1 Prophylactic and/or therapeutic agent for dysmenorrhea
12/23/2010CA2765522A1 Solid pharmaceutical composition of edoxaban having improved solubility
12/23/2010CA2765413A1 Dosage forms of apixaban
12/23/2010CA2765345A1 Peptide therapy for increasing platelet levels
12/22/2010EP2264069A2 Purification of fibrinogen
12/22/2010EP2263697A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/22/2010EP2263655A1 Pharmaceutical formulation comprising atorvastatin calcium
12/22/2010EP2262532A1 The calcium sensor STIM1 and the platelet SOC channel Orai1 (CRACM1) are essential for pathological thrombus formation
12/22/2010EP1419171B1 Methods for the synthesis of a modified hemoglobin solution
12/22/2010CN1994366B Chinese medicinal formulation for treating gynecological disease and preparation process thereof
12/22/2010CN1812973B Indazole compounds useful as protein kinase inhibitors
12/22/2010CN101925601A Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and pharmaceutical composition comprising it - 026
12/22/2010CN101925353A VEGFC production promoter
12/22/2010CN101921772A Human antibodies that bind human IL-12 and methods for producing
12/22/2010CN101921326A Recombinant decorsin mutant, preparation method and application thereof
12/22/2010CN101921267A Beta -lactamyl vasopressin Vla antagonists
12/22/2010CN101921232A Salt of 2-ring substituted pyrazolone azo derivatives, and preparation method and application thereof in medicaments
12/22/2010CN101921000A Production method of pharmaceutical-grade ferrous sulfate
12/22/2010CN101920042A Liquid bandage and preparation method
12/22/2010CN101919992A Preparation utilizing Chinese herbal medicines to reduce human body platelet filtration serum dirt and prevent and cure cerebral hemorrhage
12/22/2010CN101919968A New application of traditional Chinese medicine composition for treating headache
12/22/2010CN101919944A Traditional Chinese medicine compound, preparation method and application thereof
12/22/2010CN101919943A Medicament for preventing or treating cardiovascular and cerebrovascular diseases
12/22/2010CN101919942A Traditional Chinese medicine combination for treating gynecologic functional uterine bleeding diseases, preparation method and capsule quality control method thereof
12/22/2010CN101919938A Traditional Chinese medicine preparation for treating thrombocytopenia
12/22/2010CN101919929A Drug for treating anemia
12/22/2010CN101919917A Chinese patent medicament of cardio-cerebral nephritis-health pills
12/22/2010CN101919912A Drug for treating cerebral thrombosis
12/22/2010CN101919890A Tablet containing clopidogrel hydrogen sulfate and preparation method thereof
12/22/2010CN101919889A External angelica pus-eliminating ointment
12/22/2010CN101919864A Tolvaptan medicinal composition and preparation method thereof
12/22/2010CN101919847A Use of HIF alpha stabilizers for enhancing erythropoiesis
12/22/2010CN101919833A Application of aromatic compounds in preparing Caspase 3 inhibitor
12/22/2010CN101919823A Medicinal composition for treating thrombus
12/22/2010CN101919368A Preparation of hirudinaria manillensis and novel application thereof in Chinese medical science blood stasis
12/22/2010CN101396424B Medicine composition for treating and preventing the cardio-cerebrovascular disease and preparation method thereof
12/22/2010CN101336997B Medicine for hemorrhage after drug abortion
12/22/2010CN101301453B Chinese patent medicine powder for treating hematopathy
12/22/2010CN101264051B Modified release pharmaceutical formulation
12/22/2010CN101254272B Medicament for promoting coronary circulation and embolism resistance
12/22/2010CN101244121B Leonurus heterophyllus total alkaloid extract and preparation thereof
12/22/2010CN101057908B Heart and brain health dispersion tablet and its preparation method
12/21/2010US7855184 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells and methods of treating ophthalmic and dermatological diseases
12/21/2010US7855075 Methods of controlling proliferation and differentiation of stem and progenitor cells
12/21/2010US7855050 determining the GPVI allelotype of subjects in need of surgery, with a low platelet count, with an acquired bleeding disorder, on blood thinning drugs, or of blood donors; diagnosis of an increased risk of bleeding
12/21/2010CA2494024C Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridyl-n-2-hydroxycarbonylethyl)-amide,the preparation thereof and their use as pharmaceutical compositions
12/21/2010CA2470109C Substituted phenyl naphthalenes as estrogenic agents
12/21/2010CA2426654C 2,4,8-trisubstituted-8h-pyrido[2,3-d}pyrimidin-7-one compounds
12/21/2010CA2408596C New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
12/21/2010CA2401778C Benzamides and related inhibitors of factor xa
12/21/2010CA2397981C Azacyclic compounds for use in the treatment of serotonin related diseases
12/21/2010CA2371517C An improving agent for hypoalbuminaemia
12/21/2010CA2223833C Compounds and peptides that bind to the erythropoietin receptor
12/16/2010WO2010144904A1 Use of lcat for treating anemia and red blood cell dysfunction
12/16/2010WO2010144502A2 Growth hormone polypeptides and methods of making and using same
12/16/2010WO2010144055A1 Novel compounds and uses thereof
12/16/2010WO2010143985A1 The application of adenylate kinase to disaggregation and inhibition of aggregation of blood platelets
12/16/2010WO2010143061A1 Composition used to prevent and treat red blood cell coagulation
12/16/2010WO2010142461A2 Treatment of coagulopathy with hyperfibrinolysis
12/16/2010WO2010142309A1 Treatment of coagulopathy with hyperfibrinolysis
12/16/2010WO2010142137A1 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
12/16/2010WO2010018278A3 Composition of dialysis liquid comprising crystallisation inhibitor substances
12/16/2010US20100317854 Novel aminodicarboxylic acid derivatives having pharmaceutical properties
12/16/2010US20100317741 Method for treating septic shock or endotoxemia
12/16/2010US20100317714 Complex molecule interfering the expression of target genes and its preparing methods
12/16/2010US20100317678 Hydroxamates as inhibitors of histone deacetylase
12/16/2010US20100317669 Novel substituted piperidyl-propane-thiols
12/16/2010US20100317631 Gel Composition and Transcrotal Application of a Composition for the Treatment of Hypogonadism
12/16/2010US20100317629 Dissolvable pharmaceutical implant
12/16/2010US20100317601 Casein Derived Peptides And Uses Thereof
12/16/2010US20100317600 Process for Preparing Cardiodilatin Fragments; Highly Purified Cardiodilatin Fragments and Intermediate Products for the Preparation of Same
12/16/2010US20100317585 Long-acting coagulation factors and methods of producing same
12/16/2010US20100317584 Pharmaceutical composition, package and method for rapidly reducing the uric acid in blood
12/16/2010US20100316722 Pharmaceutical Forms for the Release of Active Compounds
12/16/2010US20100316719 B-1,3-glucan-derived polyaldehyde/polyamine hydrogel
1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 671